Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 9/2020

01-09-2020 | Translational Research and Biomarkers

Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma

Authors: Hayato Baba, MD, Mitsuro Kanda, MD, PhD, FACS, Yusuke Sato, MD, PhD, Koichi Sawaki, MD, PhD, Dai Shimizu, MD, PhD, Masahiko Koike, MD, PhD, Satoru Motoyama, MD, PhD, Yasuhiro Kodera, MD, PhD, FACS, Tsutomu Fujii, MD, PhD, FACS

Published in: Annals of Surgical Oncology | Issue 9/2020

Login to get access

Abstract

Background

β-1,4-N-Acetyl-galactosaminyltransferase 4 (B4GALNT4), an enzyme involved in ganglioside synthesis, is upregulated in many cancers. We examine B4GALNT4 expression and its relationship to prognosis in esophageal squamous cell carcinoma (ESCC).

Patients and Methods

Expression of B4GALNT4 mRNA and B4GALNT4 protein was analyzed by quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and immunohistochemistry, respectively, in 17 human ESCC cell lines and/or clinical specimens from two independent cohorts of 147 and 159 ESCC patients. The contributions of B4GALNT4 to proliferation, invasion, migration, and adhesion was evaluated in ESCC cells subjected to siRNA-mediated gene knockdown. Correlations between clinicopathological parameters and B4GALNT4 expression in clinical specimens were analyzed in both patient cohorts.

Results

B4GALNT4 mRNA expression levels varied widely in ESCC cell lines, regardless of differentiation status or the originating tissue. Knockdown of B4GALNT4 significantly suppressed the proliferation, invasion, migration, and adhesion of ESCC cell lines compared with control cells. B4GALNT4 mRNA was overexpressed in ESCC tissues compared with adjacent normal esophageal tissues. High mRNA expression was significantly associated with poor disease-free survival and hematogenous recurrence, and high B4GALNT4 protein expression was also significantly related to poor disease-specific survival. On multivariable analysis, high B4GALNT4 expression was an independent predictor of poor prognosis. In both patient cohorts, high B4GALNT4 expression did not correlate with known prognostic factors, such as disease stage, lymphovascular invasion, or squamous cell-carcinoma-related antigen level.

Conclusions

B4GALNT4 influences the malignant behavior of ESCC cells. B4GALNT4 expression may serve as a novel prognostic marker, independent of established risk factors, for ESCC patients.
Appendix
Available only for authorised users
Literature
1.
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.CrossRef
2.
Malhotra GK, Yanala U, Ravipati A, Follet M, Vijayakumar M, Are C. Global trends in esophageal cancer. J Surg Oncol. 2017;115:564–79.CrossRef
3.
Chapman BC, Weyant M, Hilton S, et al. Analysis of the National Cancer Database Esophageal Squamous Cell Carcinoma in the United States. Ann Thorac Surg. 2019;S0003-4975:31006–9.
4.
Hirano K, Matsuda A, Shirai T, Furukawa K. Expression of LacdiNAc groups on N-glycans among human tumors is complex. Biomed Res Int. 2014;2014:981627.CrossRef
5.
Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004;5:816–26.CrossRef
6.
Che MI, Huang J, Hung JS, et al. β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells. Oncotarget. 2014;5:3673–84.CrossRef
7.
Fukushima K, Satoh T, Baba S, Yamashita K. alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer. Glycobiology. 2010;20:452–60.CrossRef
8.
Anugraham M, Jacob F, Everest-Dass AV, et al. Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma. Mol Oncol. 2017;11:1595–615.CrossRef
9.
Hagiwara K, Tobisawa Y, Kaya T, et al. Wisteria floribunda agglutinin and its reactive-glycan-carrying prostate-specific antigen as a novel diagnostic and prognostic marker of prostate cancer. Int J Mol Sci. 2017;18:261.CrossRef
10.
Tsunoo H, Komura S, Ohishi N, et al. Effect of transfection with human interferon-beta gene entrapped in cationic multilamellar liposomes in combination with 5-fluorouracil on the growth of human esophageal cancer cells in vitro. Anticancer Res. 2002;22:1537-43.PubMed
11.
TNM Classification of Malignant Tumours, 8th Edition. James DB, Mary KG, Christian W, eds. New York:Wiley-Blackwell, 2016:57–62.
12.
Sato Y, Marzese DM, Ohta K, Huang SK, Sim MS, Chong K, and Hoon DS. Epigenetic regulation of REG1A and chemosensitivity of cutaneous melanoma. Epigenetics. 2013;8:1043–52.CrossRef
13.
Sato Y, Motoyama S, Nanjo H, et al. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy. Ann Surg Oncol. 2013;20:3044–51.CrossRef
14.
Sato Y, Motoyama S, Nanjo H, et al. CXCL10 expression status is prognostic in patients with advanced thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2016;23:936–42.CrossRef
15.
Kanda M, Shimizu D, Tanaka H, et al. Significance of SYT8 for the detection, prediction, and treatment of peritoneal metastasis from gastric cancer. Ann Surg. 2018;267:495–503.CrossRef
16.
17.
Kanda M, Tanaka H, Shimizu D, et al. SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells. Oncogene. 2018;37:5355–66.CrossRef
18.
Uno Y, Kanda M, Sato Y, et al. Expression, Function, and prognostic value of MAGE-D4 protein in esophageal squamous cell carcinoma. Anticancer Res. 2019;39:6015–23.CrossRef
19.
Sato Y, Motoyama S, Wakita A, et al. TLR3 expression status predicts prognosis in patients with advanced thoracic esophageal squamous cell carcinoma after esophagectomy. Am J Surg. 2018;216:319–25.CrossRef
20.
Potapenko IO, Haakensen VD, Lüders T, et al. Glycan gene expression signatures in normal and malignant breast tissue;possible role in diagnosis and progression. Mol Oncol. 2010; 4:98–118.CrossRef
21.
Zhang F, Chen X, Wei K, et al. Identification of key transcription factors associated with lung squamous cell carcinoma. Med Sci Monit. 2017;23:172–206.CrossRef
22.
Pudova EA, Lukyanova EN, Nyushko KM, et al. Differentially expressed genes associated with prognosis in locally advanced lymph node-negative prostate cancer. Front Genet. 2019;10:730.CrossRef
23.
Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 2005;;65:4645–52.CrossRef
24.
Clément M, Rocher J, Loirand G, Le Pendu J. Expression of sialyl-Tn epitopes on beta1 integrin alters epithelial cell phenotype, proliferation and haptotaxis. J Cell Sci. 2004;117:5059–69.CrossRef
25.
Huang MC, Chen HY, Huang HC, et al. C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells. Oncogene. 2006;25:3267–76.CrossRef
26.
Baba H, Kanda M, Sawaki K, et al. PRAME expression as a potential biomarker for hematogenous recurrence of esophageal squamous cell carcinoma. Anticancer Res. 2019;39:5943–51.CrossRef
27.
Wang C, Wang J, Chen Z, Gao Y, He J. Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review. Chin J Cancer. 2017;36:65.CrossRef
28.
Xiao Z, Jia Y, Jiang W, Wang Z, Zhang Z, Gao Y. FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma. Thorac Cancer. 2018;9:997–1004.CrossRef
29.
Kupcinskaite-Noreikiene R, Ugenskiene R, Noreika A, et al. Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach. BMC Cancer. 2016;16:40.CrossRef
30.
Maus MK, Hanna DL, Stephens CL, et al. Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. Pharmacogenomics J. 2015;15:354–62.CrossRef
31.
Oppedijk V, van der Gaast A, van Lanschot JJ, et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol. 2014;32:385–91.CrossRef
32.
Sohda M, Kuwano H. Current status and future prospects for esophageal cancer treatment. Ann Thorac Cardiovasc Surg. 2017;23:1–11.CrossRef
33.
Veskimäe K, Scaravilli M, Niininen W, et al. Expression analysis of platinum sensitive and resistant epithelial ovarian cancer patient samples reveals new candidates for targeted therapies. Transl Oncol. 2018;11:1160–70.CrossRef
Metadata
Title
Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma
Authors
Hayato Baba, MD
Mitsuro Kanda, MD, PhD, FACS
Yusuke Sato, MD, PhD
Koichi Sawaki, MD, PhD
Dai Shimizu, MD, PhD
Masahiko Koike, MD, PhD
Satoru Motoyama, MD, PhD
Yasuhiro Kodera, MD, PhD, FACS
Tsutomu Fujii, MD, PhD, FACS
Publication date
01-09-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 9/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08431-8

Other articles of this Issue 9/2020

Annals of Surgical Oncology 9/2020 Go to the issue

Colorectal Cancer

Oncological Impact of Lateral Lymph Node Dissection After Preoperative Chemoradiotherapy in Patients with Rectal Cancer

Hepatobiliary Tumors

Surgical Indications for Hepatocellular Carcinoma with Non-hypervascular Hypointense Nodules Detected by Gd-EOB-DTPA-Enhanced MRI

ASO Author Reflections

ASO Author Reflections: Involvement of Intracellular and Extracellular High-Mobility Group Box-1 in the Progression of Esophageal Squamous Cell Carcinoma

Thoracic Oncology

Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus

Health Services Research and Global Oncology

Reframing Quality of Care Discussions in Surgery: Shifting from Surgeon Focus to Patient Perspectives

ASO Author Reflections

ASO Author Reflections: Analyzing the Trends for Axillary Lymph Node Surgery in Patients with Ductal Carcinoma In Situ: A Comparison Against National Guidelines